GoldenTree's 21.2% stake and $42.1M recent purchase signal strong conviction. Watch for potential board representation demands, strategic review push, or operational changes given the issuer's pharmaceutical focus and prior restructuring history.
Executive Summary
GoldenTree Asset Management LP filed an amended Schedule 13D disclosing a 21.2% stake in Keenova Therapeutics plc as of September 24, 2026, after purchasing 463,000 ordinary shares for $42.1 million. This is the first filing by GoldenTree on this issuer, indicating a new activist position with significant ownership. The stake was built using working capital, suggesting conviction and a potential catalyst-driven thesis.
Key Financial Metrics
Key Facts
- GoldenTree Asset Management LP now beneficially owns 8,389,212 ordinary shares (21.2% of outstanding) plus 53,615 shares held directly by Steven A. Tananbaum, for a total of 8,442,827 shares (21.3%).
- On September 24, 2026, GoldenTree purchased 463,000 ordinary shares for $42,133,000 using working capital.
- The ownership percentage is based on 39,646,277 ordinary shares outstanding as of August 4, 2026, per the issuer's Form 10-Q filed August 11, 2026.
- This is Amendment No. 1 to a Schedule 13D originally filed August 7, 2025, but the current filing is the first to disclose a specific stake percentage and transaction details.
Financial Impact
GoldenTree spent $42.1 million on 463,000 shares at an average price of ~$91.00 per share, building a 21.2% stake.
Risk Factors
- Activist may push for changes that management resists, leading to proxy fight or litigation.
- Issuer's complex capital structure and prior Chapter 11 history could complicate activist objectives.
- GoldenTree's demands are not yet disclosed; uncertainty around specific catalyst.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001493152-26-045957 |
| Document: 0001493152-26-045957-index.html | 0001493152-26-045957 |
| Document: 0001493152-26-045957.txt | 0001493152-26-045957 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers